The capital market regulator, in its January 2 order, barred both Parekh and Singapore-based Rohit Salgaocar, who was a ...
Dr Reddy’s share price rose nearly 4% after Nuvama Institutional Equities upgraded its rating to ’Buy’ with a target of ...
On January 2, the Securities and Exchange Board of India (SEBI) debarred Dalal Street scam-tainted trader Ketan Parekh and ...
Sagar Doshi of Nuvama Professional Clients Group recommends these three stocks today- Oil and Natural Gas Corporation Ltd ...
Mixed Q3FY25 outlook for retail industry with jewellery and value retail leading growth, footwear and apparel showing ...
The retail sector delivered a mixed performance during the festive season, with select pockets emerging as bright spots, ...
Non-life insurers reported a marginal decline in premiums in December due to a revision in premium accounting norms by the ...
Nirmal Bang Institutional Equities is expecting Wipro to report 16.6 per cent year-on-year (YoY) rise in adjusted net profit ...
The share sale window of OrbiMed-backed Laxmi Dental will open on Monday, January 13, 2025, to raise Rs 698 crore and will ...
Laxmi Dental's Rs 698 crore IPO opens next week with a price band of Rs 407-428 per share. The IPO comprises fresh issue and ...
At a time when the Securities and Exchange Board of India (SEBI) has itself come under a cloud, an ex-parte order, issued on 2nd January against Ketan Parekh (KP) and 21 associates, makes for ...
Dr. Reddys Laboratories shares rose 4% after Nuvama upgraded its rating to 'buy,' citing proactive strategies to mitigate the ...